Atlas Venture
Cambridge, MA–based biotech venture firm that creates and builds early-stage life-sciences companies, partnering with scientists from company formation through Series A.
Typical check size
$1M-$10M (stage-based estimate)
Founded
1980
Headquarters
Cambridge, MA
AUM
N/A
Rounds they lead
Seed
Series A
Rounds they invest
Seed
Series A
Related investment articles
FAQs about Atlas Venture
Stage fit, check size, thesis, and how founders typically approach this firm — based on public sources and our directory.
Atlas leads Seed and Series A rounds in biotech. The firm is known for company creation — incubating startups internally before or alongside first institutional financings.
Atlas does not publish a standard check-size range. As a biotech company-builder, initial financings are sized to hit defined R&D milestones rather than a fixed ticket.
Headquartered in Cambridge, MA, in the heart of the Boston/Cambridge biotech cluster. Atlas primarily backs U.S. life-sciences startups, often tied to regional research institutions.
Atlas focuses exclusively on biotechnology and life sciences — therapeutics, platform biology, and related modalities — through a science-first, company-formation model.
Atlas typically leads seed and Series A rounds in companies it helps found or incubate. It is an active board-level partner, not a passive follower.
We do not yet have portfolio companies linked to Atlas Venture in our directory. Atlas’s public portfolio is listed at atlasventure.com.
Atlas engages entrepreneurial scientists and repeat biotech operators — often before a company is fully formed. Introductions through scientific networks, prior Atlas entrepreneurs, or co-investors in the Boston biotech ecosystem are the practical path.
No dedicated Atlas article in our blog yet. See the fund profile at /fund/atlas-venture.